Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-05-16
1991-11-05
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 514 17, A61K 3702, C07K 708
Patent
active
050632060
ABSTRACT:
The present invention relates to methods of treating mental disorders and memory deficits not caused by HIV infection. The methods involve administration of a thymoleptic effective amount of defined linear peptides to patients. The peptides can be administered for example, as a powder or a solution obtained by dissolving a powder in a pharmaceutically acceptable solvent.
REFERENCES:
patent: 4596795 (1986-06-01), Pitha
patent: 4659696 (1987-04-01), Hirai et al.
Pert, C., et al., Psychopharmacology Bull., 24(3):315-319, 1988.
Pert, C. et al., Ann. Neurol., 23(Suppl.): S71-S73, 1988.
Brenneman, D., et al., Drug Development Research, 15:361-369, 1988.
Pert, C., et al., Proc. Natl. Acad. Sci, U.S.A., 83:9254-9258, Dec. 1986.
Ruff, M., et al., FEBS Letters, 211(1):17-22, Jan. 1987.
Berger, J., AIDS: Modern Concepts & Therapeutic Challenges, pp. 263-283, 1987.
Joy et al., Cerebral infarction following herpes zoster: The enlarging clinical spectrum, Neurology, Dec. 1989, pp. 1640-1641.
Gotham et al., `Frontal` Cognitive Function in Patients with Parkinson's Disease `on` and `off` Levodopa, Brain 1988, pp. 299-321.
Starkstein et al., Depression and Cognitive Impairment in Parkinson's Disease, Brain 1989, pp. 1141-1153.
Ala et al., GM-1 Treatment of Alzheimer's Diease, Arch Neurol, vol. 47, Oct. 1990, pp. 1126-1130.
Taylor et al., Parkinson's Disease, Brain, 1987, pp. 35-51.
Bridge Peter
Goodwin Frederick K.
Perkins Susan M.
Schain Howard E.
The United States of Americas as represented by the Department o
LandOfFree
Compositions having use as treatment of neuropsychiatric deficit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions having use as treatment of neuropsychiatric deficit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions having use as treatment of neuropsychiatric deficit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-499319